ALIVE is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem of strategic partners comprising leading hospital chains, HMOs and financial institutions to support and accelerate portfolio companies’ clinical and commercial expansion.

Our goal is to optimize value creation across all stages of our investment journey; from clinical trials and FDA approvals, through market validation and product adoption, to successful entry into capital markets and strategic deals.

We invest in promising mid-to-late stage companies developing innovative platform technologies that will become the gold standard in a broad range of disciplines.

We look for highly fundable companies with strong management, broad IP protection and a proven track record of execution, that are poised to benefit from the strategic synergies offered by the ALIVE ecosystem.


Leave a Reply